Live Nation Entertainment In (LYV) Shareholder Axel Capital Management Has Trimmed Its Holding as Market Value Declined; Celgene Com (CELG) Stock Price Declined While Zeke Capital Advisors Has Lowered Its Holding by $547,560

May 15, 2018 - By Peter Mason

Live Nation Entertainment, Inc. (NYSE:LYV) Logo

Zeke Capital Advisors Llc decreased its stake in Celgene Corp Com (CELG) by 40.08% based on its latest 2017Q4 regulatory filing with the SEC. Zeke Capital Advisors Llc sold 5,265 shares as the company’s stock declined 19.30% with the market. The hedge fund held 7,870 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $821,000, down from 13,135 at the end of the previous reported quarter. Zeke Capital Advisors Llc who had been investing in Celgene Corp Com for a number of months, seems to be less bullish one the $59.78 billion market cap company. The stock decreased 3.53% or $3.01 during the last trading session, reaching $82.3. About 4.62 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 15, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Anna Nikolayevsky decreased its stake in Live Nation Entertainment In (LYV) by 47.17% based on its latest 2017Q4 regulatory filing with the SEC. Axel Capital Management Llc sold 75,000 shares as the company’s stock declined 0.07% with the market. The hedge fund run by Anna Nikolayevsky held 84,000 shares of the consumer services company at the end of 2017Q4, valued at $3.58 million, down from 159,000 at the end of the previous reported quarter. Axel Capital Management Llc who had been investing in Live Nation Entertainment In for a number of months, seems to be less bullish one the $9.15 billion market cap company. The stock increased 2.53% or $1.08 during the last trading session, reaching $43.8. About 986,119 shares traded. Live Nation Entertainment, Inc. (NYSE:LYV) has risen 41.79% since May 15, 2017 and is uptrending. It has outperformed by 30.24% the S&P500.

Among 14 analysts covering Live Nation (NYSE:LYV), 13 have Buy rating, 0 Sell and 1 Hold. Therefore 93% are positive. Live Nation had 27 analyst reports since September 18, 2015 according to SRatingsIntel. The stock has “Buy” rating by Gabelli on Friday, September 18. Citigroup upgraded Live Nation Entertainment, Inc. (NYSE:LYV) on Monday, April 9 to “Buy” rating. Northcoast upgraded the stock to “Buy” rating in Monday, May 2 report. The rating was initiated by JP Morgan on Thursday, August 18 with “Overweight”. Jefferies maintained the shares of LYV in report on Monday, October 16 with “Buy” rating. The company was maintained on Wednesday, January 10 by Guggenheim. Goldman Sachs initiated the shares of LYV in report on Monday, April 3 with “Buy” rating. The stock of Live Nation Entertainment, Inc. (NYSE:LYV) earned “Buy” rating by Macquarie Research on Wednesday, August 9. The stock of Live Nation Entertainment, Inc. (NYSE:LYV) earned “Overweight” rating by Stephens on Tuesday, November 8. As per Friday, May 4, the company rating was upgraded by Evercore.

Analysts await Live Nation Entertainment, Inc. (NYSE:LYV) to report earnings on August, 8. They expect $0.27 EPS, down 6.90% or $0.02 from last year’s $0.29 per share. LYV’s profit will be $56.41 million for 40.56 P/E if the $0.27 EPS becomes a reality. After $-0.24 actual EPS reported by Live Nation Entertainment, Inc. for the previous quarter, Wall Street now forecasts -212.50% EPS growth.

More recent Live Nation Entertainment, Inc. (NYSE:LYV) news were published by: Globenewswire.com which released: “Kaskela Law LLC: Shareholder Class Action Filed Against Live Nation Entertainment – LYV” on May 06, 2018. Also Prnewswire.com published the news titled: “Live Nation Entertainment Launches Women Nation Fund To Invest In Female-Founded Live Music Businesses” on May 15, 2018. Businesswire.com‘s news article titled: “LYV SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Live …” with publication date: May 10, 2018 was also an interesting one.

Investors sentiment decreased to 1.15 in Q4 2017. Its down 0.39, from 1.54 in 2017Q3. It dived, as 41 investors sold LYV shares while 99 reduced holdings. 63 funds opened positions while 98 raised stakes. 136.81 million shares or 1.26% more from 135.10 million shares in 2017Q3 were reported. Amp Capital Investors Limited reported 32,151 shares. Earnest Ptnrs Limited Liability Co holds 86 shares or 0% of its portfolio. Sterling Cap Management accumulated 1.44M shares. Great West Life Assurance Can reported 0.01% of its portfolio in Live Nation Entertainment, Inc. (NYSE:LYV). Northern Tru reported 0.02% stake. Wellington Mngmt Gp Llp owns 0% invested in Live Nation Entertainment, Inc. (NYSE:LYV) for 11,223 shares. First Republic stated it has 0% of its portfolio in Live Nation Entertainment, Inc. (NYSE:LYV). Loomis Sayles & LP has invested 0.06% of its portfolio in Live Nation Entertainment, Inc. (NYSE:LYV). Nordea Investment Mngmt Ab accumulated 0.02% or 214,657 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt has invested 0.01% in Live Nation Entertainment, Inc. (NYSE:LYV). Louisiana State Employees Retirement Systems reported 33,900 shares or 0.07% of all its holdings. 554,018 were accumulated by Epoch. Wisconsin-based Northwestern Mutual Wealth has invested 0% in Live Nation Entertainment, Inc. (NYSE:LYV). New York-based M&T Retail Bank Corporation has invested 0% in Live Nation Entertainment, Inc. (NYSE:LYV). New York-based Diker Limited Liability Company has invested 1.53% in Live Nation Entertainment, Inc. (NYSE:LYV).

Axel Capital Management Llc, which manages about $80.05M and $101.86M US Long portfolio, upped its stake in Sba Communications Corp New by 2,300 shares to 9,300 shares, valued at $1.52 million in 2017Q4, according to the filing.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Streetinsider.com which released: “Vertex Pharma (VRTX), Alexion Pharma (ALXN) Least Impacted from Trump Drug Policies – RBC” on May 15, 2018, also Seekingalpha.com with their article: “A Fresh Look At Celgene After Q1 And New Info On Ozanimod” published on May 08, 2018, Seekingalpha.com published: “Celgene And Otezla Are Cracking” on May 14, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Seekingalpha.com and their article: “Celgene Earnings Preview” published on April 30, 2018 as well as Fool.com‘s news article titled: “Celgene Starts the Year With a Bang” with publication date: May 14, 2018.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on July, 26. They expect $1.87 earnings per share, up 11.31% or $0.19 from last year’s $1.68 per share. CELG’s profit will be $1.36 billion for 11.00 P/E if the $1.87 EPS becomes a reality. After $1.61 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts 16.15% EPS growth.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 146 analyst reports since July 21, 2015 according to SRatingsIntel. As per Friday, May 5, the company rating was downgraded by Argus Research. Credit Suisse initiated Celgene Corporation (NASDAQ:CELG) on Wednesday, January 20 with “Outperform” rating. Raymond James initiated the shares of CELG in report on Tuesday, September 1 with “Strong-Buy” rating. The company was maintained on Friday, April 13 by Morgan Stanley. BMO Capital Markets maintained it with “Outperform” rating and $148 target in Friday, October 27 report. The stock of Celgene Corporation (NASDAQ:CELG) has “Outperform” rating given on Monday, October 30 by Oppenheimer. Jefferies maintained the shares of CELG in report on Sunday, August 13 with “Buy” rating. The rating was maintained by SunTrust with “Buy” on Friday, December 22. The stock of Celgene Corporation (NASDAQ:CELG) earned “Equal-Weight” rating by Barclays Capital on Friday, October 27. Canaccord Genuity maintained Celgene Corporation (NASDAQ:CELG) rating on Monday, October 16. Canaccord Genuity has “Buy” rating and $156.0 target.

Since February 8, 2018, it had 1 insider purchase, and 3 insider sales for $3.58 million activity. 13,370 Celgene Corporation (NASDAQ:CELG) shares with value of $1.26M were sold by MARIO ERNEST. LOUGHLIN JAMES J also sold $851,093 worth of Celgene Corporation (NASDAQ:CELG) on Monday, March 12. Another trade for 3,260 shares valued at $299,594 was made by Alles Mark J on Thursday, February 8.

Live Nation Entertainment, Inc. (NYSE:LYV) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Mason

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: